| Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ... J Hepatol 71 (2), 265-273, 2019 | 167* | 2019 |
| Association between PNPLA3 rs738409 C> G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease S Grimaudo, RM Pipitone, G Pennisi, C Celsa, C Cammà, V Di Marco, ... Clinical Gastroenterology and Hepatology 18 (4), 935-944. e3, 2020 | 127 | 2020 |
| Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 78 | 2022 |
| Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysis M Tacelli, C Celsa, B Magro, M Barchiesi, L Barresi, G Capurso, ... Digestive Endoscopy 32 (7), 1018-1030, 2020 | 62 | 2020 |
| Antidiabetic drugs in NAFLD: the accomplishment of two goals at once? M Tacelli, C Celsa, B Magro, A Giannetti, G Pennisi, F Spatola, S Petta Pharmaceuticals 11 (4), 121, 2018 | 61 | 2018 |
| Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 E Villa, R Critelli, S Lasagni, A Melegari, A Curatolo, C Celsa, ... Blood advances 5 (3), 662-673, 2021 | 54 | 2021 |
| Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: systematic review and meta-analysis M Tacelli, C Celsa, B Magro, L Barresi, S Guastella, G Capurso, L Frulloni, ... Clinical Gastroenterology and Hepatology 17 (6), 1061-1072. e8, 2019 | 51 | 2019 |
| Efficacy of lumen-apposing metal stents or self-expandable metal stents for endoscopic ultrasound-guided choledochoduodenostomy: a systematic review and meta-analysis A Amato, E Sinagra, C Celsa, M Enea, A Buda, F Vieceli, L Scaramella, ... Endoscopy 53 (10), 1037-1047, 2021 | 49 | 2021 |
| The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: screening issue and future perspectives G Pennisi, C Celsa, A Giammanco, F Spatola, S Petta International journal of molecular sciences 20 (22), 5613, 2019 | 49 | 2019 |
| Biliary complications after liver transplantation: current perspectives and future strategies B Magro, M Tacelli, A Mazzola, F Conti, C Celsa Hepatobiliary Surgery and Nutrition 10 (1), 76, 2021 | 42 | 2021 |
| The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib F Caputo, V Dadduzio, F Tovoli, G Bertolini, G Cabibbo, K Cerma, ... PLoS One 15 (5), e0232449, 2020 | 39 | 2020 |
| Real-life clinical data of lenvatinib versus sorafenib for unresectable hepatocellular carcinoma in Italy V Burgio, M Iavarone, GG Di Costanzo, F Marra, S Lonardi, E Tamburini, ... Cancer Management and Research, 9379-9389, 2021 | 35 | 2021 |
| AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD G Pennisi, M Enea, A Pandolfo, C Celsa, M Antonucci, C Ciccioli, ... Clinical Gastroenterology and Hepatology 21 (5), 1293-1302. e5, 2023 | 34 | 2023 |
| Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use B Magro, V Zuccaro, L Novelli, L Zileri, C Celsa, F Raimondi, M Gori, ... PloS one 16 (1), e0245281, 2021 | 34 | 2021 |
| Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives G Pennisi, C Celsa, F Spatola, M Dallio, A Federico, S Petta International Journal of Environmental Research and Public Health 16 (22), 4334, 2019 | 34 | 2019 |
| First-line immune checkpoint inhibitor-based sequential therapies for advanced hepatocellular carcinoma: rationale for future trials G Cabibbo, M Reig, C Celsa, F Torres, S Battaglia, M Enea, GEM Rizzo, ... Liver Cancer 11 (1), 75-84, 2022 | 33 | 2022 |
| Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept A Vitale, G Cabibbo, M Iavarone, L Viganò, DJ Pinato, FR Ponziani, Q Lai, ... The Lancet Oncology 24 (7), e312-e322, 2023 | 32 | 2023 |
| Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) V Zuccaro, C Celsa, M Sambo, S Battaglia, P Sacchi, S Biscarini, ... Scientific reports 11 (1), 1137, 2021 | 30 | 2021 |
| Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? G Cabibbo, C Celsa, C Cammà, A Craxì Liver International 38 (12), 2108-2116, 2018 | 26 | 2018 |
| Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: A systematic review with meta-analysis of aggregate and individual data M Tacelli, N Bina, SF Crinò, A Facciorusso, C Celsa, AS Vanni, A Fantin, ... Gastrointestinal Endoscopy 96 (6), 898-908. e23, 2022 | 23 | 2022 |
Calogero CammàSection of Gastroenterology, University of PalermoEmail verificata su unipa.it
